All Posts
Grateful Patient Day 2020
Home / Blog Post / Grateful Patient Day 2020 On September 7th, 2020 the Cholangiocarcinoma Foundation (CCF) participated in Grateful…
Green Out for Our Baseball Coach
Home / Blog Post / Green Out for Our Baseball Coach Cancer doesn’t just change the life of the patient;…
Caring for the Caregiver
Home / Blog Post / The woman who forgot today Being a caregiver is the role of a lifetime. I…
Five for Friday - 5 ways you can share your gratitude
Home / COVID-19 / [wpbb post:title] Grateful Patient Day is coming up on September 7th, 2020 and we want you to…
Remembering Dr. Supriya 'Shoop' Saha
Home / Blog Post / Remembering Dr. Supriya ‘Shoop’ Saha By: Nabeel M. Bardeesy, PhD and Allison Deragon Dr. Supriya…
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Study Name Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) After High-Dose External Beam Radiation Therapy in Treating…
The woman who forgot today
Home / Blog Post / The woman who forgot today We should, I thought, be compatriots: brothers-in-arms who'd lost their…
Five for Friday - 5 Resources to Help Navigate Depression.
Home / COVID-19 / [wpbb post:title] During our 2020 Annual conference, Incyte shared the results from a 700 patient survey. The…
A Phase II study of induction systemic mFOLFIRINOX followed by hepatic arterial infusion of Floxuridine and Dexamethasone given concurrently with systemic mFOLFIRI as a first-line therapy in patients with unresectable liver-dominant intrahepatic cholangiocarcinoma (HELIX-ICC)
Study Name A Phase II study of induction systemic mFOLFIRINOX followed by hepatic arterial infusion of Floxuridine and Dexamethasone given…
Five for Friday - 5 Events to Add to Your Calendar
Home / COVID-19 / [wpbb post:title] The future is looking bright at the Cholangiocarcinoma Foundation thanks to YOU! We have…